MET and myeloproliferative disorder: Since CD34+ progenitors from patients with Ph+ MPN or with myelodisplastic syndrome (MDS) show aberrant c-MET expression on their membrane, an autocrine loop of activation of the HGF/c-MET pathway should be envisaged [16].